- Home
- » Tags
- » Penciclovir
Top View
- Sharp Health Plan 2020 Formulary List of Covered Prescription Drugs
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Comparison of New Topical Treatments for Herpes Labialis
- Drug Discovery of Nucleos(T)Ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80Th Birthday
- Medicaid List of Covered Drugs (Formulary)
- 1 Identification of Potent Drugs and Antiviral Agents for the Treatment Of
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Antivirals, Topical
- Novel Coronavirus Treatment with Ribavirin: Groundwork for Evaluation Concerning COVID‐19
- (IARC), “Monographs on the Evaluation of Carcinogenic Risks To
- Tenncare Attestation List September 1, 2021
- Computational Drug Repurposing Study Elucidating Simultaneous Inhibition of Entry and Replication of Novel Corona Virus by Grazoprevir
- Uses and Administration Adverse Effects Profile Profile Profile Uses
- Therapeutic Options for Herpes Labialis, I: Oral Agents
- Topical and Systemic Therapies for Oral and Perioral Herpes Simplex Virus Infections
- Pharmacokinetics of Penciclovir After Oral Administration of Its Prodrug Famciclovir to Horses
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Tenncare Prescriber Attestation List
- Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2019
- Herpes Simplex and Varicella-Zoster Infections
- Hepatitis B and C
- Legacy Appendices
- SYNTHESIS, CHARACTERIZATIONAND ANTIVIRAL PROPERTIES of Pd(II) COMPLEXES with PENCICLOVIR
- USP Medicare Model Guidelines V7.0 (With Example Part D Drugs)
- Signature Redacted Signature of Author: Department of Biology January 29, 2020
- Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed-Dose Combination (B/F/Taf Fdc)
- Pharmaceutical Ingredients in Drinking Water: Overview of Occurrence and Significance of Human Exposure
- Herpes Simplex Virus Infection (1 of 9)
- Therapeutic Class Overview Topical Antivirals
- 203791Orig1s000
- Controlled Release Delivery of Penciclovir Via A
- Aciclovir a Reappraisal of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy
- The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus
- 2013 March (127): Treatment Guidelines
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
- Tenofovir Disoproxil Fumarate for the Treatment of Hepatitis B Virus Infection: Pharmacokinetics and Clinical Efficacy
- A Review of Antiviral Drugs and Other Compounds with Activity Against Feline Herpesvirus Type 1
- Tenofovir Prodrugs Potently Inhibit Epstein–Barr Virus Lytic DNA Replication by Targeting the Viral DNA Polymerase
- Exploring the Selectivity of Guanine Scaffold in Anticancer Drug
- Resolution Ap (2000) 1
- Antiviral Agents Topical
- ARPEC Protocol for Drug Utilization Study
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012
- Tenofovir Prodrugs Potently Inhibit Epstein–Barr Virus Lytic DNA Replication by Targeting the Viral DNA Polymerase
- Effective 07-01-2021) the Florida Medicaid Preferred Drug List (PDL